Cargando…

Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis

The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level de...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Guoxin, Wu, Xinbo, Yu, Shunzhi, Sun, Qi, Guan, Xiaofei, Zhang, Hailong, Gu, Xin, He, Shisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056235/
https://www.ncbi.nlm.nih.gov/pubmed/27747244
http://dx.doi.org/10.1155/2016/9540298
_version_ 1782458857773072384
author Fan, Guoxin
Wu, Xinbo
Yu, Shunzhi
Sun, Qi
Guan, Xiaofei
Zhang, Hailong
Gu, Xin
He, Shisheng
author_facet Fan, Guoxin
Wu, Xinbo
Yu, Shunzhi
Sun, Qi
Guan, Xiaofei
Zhang, Hailong
Gu, Xin
He, Shisheng
author_sort Fan, Guoxin
collection PubMed
description The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level degenerative lumbar spinal stenosis who underwent MIS-TLIF or PLIF from January 2010 to February 2012. Back and leg visual analog scale (VAS), Oswestry Disability Index (ODI), and Short Form-36 (SF-36) scale were used to assess the pain, disability, and health status before surgery and postoperatively. In addition, the operating time, estimated blood loss, and hospital stay were also recorded. There were no significant differences in back VAS, leg VAS, ODI, SF-36, fusion condition, and complications at 12-month follow-up between the two groups (P > 0.05). However, significantly less blood loss and shorter hospital stay were observed in MIS-TLIF group (P < 0.05). Moreover, patients undergoing MIS-TLIF had significantly lower back VAS than those in PLIF group at 6-month follow-up (P < 0.05). Compared with PLIF, MIS-TLIF might be a prior option because of noninferior efficacy as well as merits of less blood loss and quicker recovery in treating three-level lumbar spinal stenosis.
format Online
Article
Text
id pubmed-5056235
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50562352016-10-16 Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis Fan, Guoxin Wu, Xinbo Yu, Shunzhi Sun, Qi Guan, Xiaofei Zhang, Hailong Gu, Xin He, Shisheng Biomed Res Int Clinical Study The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level degenerative lumbar spinal stenosis who underwent MIS-TLIF or PLIF from January 2010 to February 2012. Back and leg visual analog scale (VAS), Oswestry Disability Index (ODI), and Short Form-36 (SF-36) scale were used to assess the pain, disability, and health status before surgery and postoperatively. In addition, the operating time, estimated blood loss, and hospital stay were also recorded. There were no significant differences in back VAS, leg VAS, ODI, SF-36, fusion condition, and complications at 12-month follow-up between the two groups (P > 0.05). However, significantly less blood loss and shorter hospital stay were observed in MIS-TLIF group (P < 0.05). Moreover, patients undergoing MIS-TLIF had significantly lower back VAS than those in PLIF group at 6-month follow-up (P < 0.05). Compared with PLIF, MIS-TLIF might be a prior option because of noninferior efficacy as well as merits of less blood loss and quicker recovery in treating three-level lumbar spinal stenosis. Hindawi Publishing Corporation 2016 2016-09-26 /pmc/articles/PMC5056235/ /pubmed/27747244 http://dx.doi.org/10.1155/2016/9540298 Text en Copyright © 2016 Guoxin Fan et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Fan, Guoxin
Wu, Xinbo
Yu, Shunzhi
Sun, Qi
Guan, Xiaofei
Zhang, Hailong
Gu, Xin
He, Shisheng
Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis
title Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis
title_full Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis
title_fullStr Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis
title_full_unstemmed Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis
title_short Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis
title_sort clinical outcomes of posterior lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in three-level degenerative lumbar spinal stenosis
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056235/
https://www.ncbi.nlm.nih.gov/pubmed/27747244
http://dx.doi.org/10.1155/2016/9540298
work_keys_str_mv AT fanguoxin clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis
AT wuxinbo clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis
AT yushunzhi clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis
AT sunqi clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis
AT guanxiaofei clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis
AT zhanghailong clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis
AT guxin clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis
AT heshisheng clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis